{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:13:37Z","timestamp":1790090017563,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,6]]},"DOI":"10.7759\/cureus.35843","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T01:09:05Z","timestamp":1678151345000},"source":"Crossref","is-referenced-by-count":7,"title":["Pharmacologic Management of Intensive Care Unit Delirium and the Impact on the Duration of Delirium, Length of Intensive Care Unit Stay and 30-Day Mortality: A Network Meta-Analysis of Randomized-Control Trials"],"prefix":"10.7759","author":[{"given":"Muhammad Sohaib","family":"Afzal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folajimi J","family":"Atunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rao Ahmed","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namra","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnana Deepthi","family":"Medarametla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazar","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.14.1753","article-title":"Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit","volume":"291","author":"Ely EW","year":"2004","unstructured":"Ely EW, Shintani A, Truman B, et al.. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004, 291:1753-62. 10.1001\/jama.291.14.1753","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s001340101017","article-title":"Delirium in an intensive care unit: a study of risk factors","volume":"27","author":"Dubois MJ","year":"2001","unstructured":"Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med. 2001, 27:1297-304. 10.1007\/s001340101017","journal-title":"Intensive Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-001-1132-2","article-title":"The impact of delirium in the intensive care unit on hospital length of stay","volume":"27","author":"Ely EW","year":"2001","unstructured":"Ely EW, Gautam S, Margolin R, et al.. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001, 27:1892-900. 10.1007\/s00134-001-1132-2","journal-title":"Intensive Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-006-0399-8","article-title":"Incidence, risk factors and consequences of ICU delirium","volume":"33","author":"Ouimet S","year":"2007","unstructured":"Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007, 33:66-73. 10.1007\/s00134-006-0399-8","journal-title":"Intensive Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2022\/56141.16615","article-title":"Comparison of haloperidol and quetiapine for treatment of delirium in critical illness: a prospective randomised double-blind placebo-controlled trial","volume":"1","author":"Garg R","year":"2022","unstructured":"Garg R, Singh VK, Singh G. Comparison of haloperidol and quetiapine for treatment of delirium in critical illness: a prospective randomised double-blind placebo-controlled trial. J Clin Diagn Res. 2022, 1:16. 10.7860\/JCDR\/2022\/56141.16615","journal-title":"J Clin Diagn Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000119429.16055.92","article-title":"Costs associated with delirium in mechanically ventilated patients","volume":"32","author":"Milbrandt EB","year":"2004","unstructured":"Milbrandt EB, Deppen S, Harrison PL, et al.. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004, 32:955-62. 10.1097\/01.ccm.0000119429.16055.92","journal-title":"Crit Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-%23","article-title":"The frequency and clinical course of cognitive impairment in patients with terminal cancer","volume":"79","author":"Pereira J","year":"2000","unstructured":"Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 2000, 79:835-42. 10.1002\/(SICI)1097-0142(19970215)79:4&lt;835::AID-CNCR21&gt;3.0.CO;2-%23","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1273759","article-title":"Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: a review","volume":"44","author":"Grover S","year":"2011","unstructured":"Grover S, Mattoo SK, Gupta N. Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: a review. Pharmacopsychiatry. 2011, 44:43-54. 10.1055\/s-0031-1273759","journal-title":"Pharmacopsychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2700.199520","article-title":"Delirium in the intensive care unit","volume":"10","author":"Arumugam S","year":"2017","unstructured":"Arumugam S, El-Menyar A, Al-Hassani A, et al.. Delirium in the intensive care unit. J Emerg Trauma Shock. 2017, 10:37-46. 10.4103\/0974-2700.199520","journal-title":"J Emerg Trauma Shock"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002640","article-title":"Worldwide survey of the \u201cAssessing pain, Both spontaneous awakening and breathing trials, Choice of drugs, Delirium monitoring\/management, Early exercise\/mobility, and Family empowerment\u201d (ABCDEF) bundle","volume":"45","author":"Morandi A","year":"2017","unstructured":"Morandi A, Piva S, Ely EW, et al.. Worldwide survey of the \u201cAssessing pain, Both spontaneous awakening and breathing trials, Choice of drugs, Delirium monitoring\/management, Early exercise\/mobility, and Family empowerment\u201d (ABCDEF) bundle. Crit Care Med. 2017, 45:e1111-22. 10.1097\/CCM.0000000000002640","journal-title":"Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005594.pub3","article-title":"Antipsychotics for treatment of delirium in hospitalised non-ICU patients","volume":"6","author":"Burry L","year":"2018","unstructured":"Burry L, Mehta S, Perreault MM, et al.. Antipsychotics for treatment of delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2018, 6:CD005594. 10.1002\/14651858.CD005594.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181b9e302","article-title":"Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study","volume":"38","author":"Devlin JW","year":"2010","unstructured":"Devlin JW, Roberts RJ, Fong JJ, et al.. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010, 38:419-27. 10.1097\/CCM.0b013e3181b9e302","journal-title":"Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0b013e3181c58715","article-title":"Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial","volume":"38","author":"Girard TD","year":"2010","unstructured":"Girard TD, Pandharipande PP, Carson SS, et al.. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med. 2010, 38:428-37. 10.1097\/ccm.0b013e3181c58715","journal-title":"Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001411","article-title":"Preventing ICU subsyndromal delirium conversion to delirium with low dose IV haloperidol: a double-blind, placebo-controlled pilot study","volume":"44","author":"Al-Qadheeb NS","year":"2016","unstructured":"Al-Qadheeb NS, Skrobik Y, Schumaker G, Pacheco MN, Roberts RJ, Ruthazer RR, Devlin JW. Preventing ICU subsyndromal delirium conversion to delirium with low dose IV haloperidol: a double-blind, placebo-controlled pilot study. Crit Care Med. 2016, 44:583-91. 10.1097\/CCM.0000000000001411","journal-title":"Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0160","article-title":"Effect of haloperidol on survival among critically ill adults with a high risk of delirium: the REDUCE randomized clinical trial","volume":"319","author":"van den Boogaard M","year":"2018","unstructured":"van den Boogaard M, Slooter AJ, Br\u00fcggemann RJ, et al.. Effect of haloperidol on survival among critically ill adults with a high risk of delirium: the REDUCE randomized clinical trial. JAMA. 2018, 319:680-90. 10.1001\/jama.2018.0160","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808217","article-title":"Haloperidol and ziprasidone for treatment of delirium in critical illness","volume":"379","author":"Girard TD","year":"2018","unstructured":"Girard TD, Exline MC, Carson SS, et al.. Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med. 2018, 379:2506-16. 10.1056\/NEJMoa1808217","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182376e4f","article-title":"Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial","volume":"40","author":"Wang W","year":"2012","unstructured":"Wang W, Li HL, Wang DX, et al.. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial. Crit Care Med. 2012, 40:731-9. 10.1097\/CCM.0b013e3182376e4f","journal-title":"Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2005.01355.x","article-title":"Antipsychotics and dopamine transporter gene polymorphisms in delirium patients","volume":"59","author":"Kim JY","year":"2005","unstructured":"Kim JY, Jung IK, Han C, et al.. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci. 2005, 59:183-8. 10.1111\/j.1440-1819.2005.01355.x","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(04)70170-X","article-title":"A double-blind trial of risperidone and haloperidol for the treatment of delirium","volume":"45","author":"Han C","year":"2004","unstructured":"Han C, Kim Y. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics. 2004, 45:297-301. 10.1016\/S0033-3182(04)70170-X","journal-title":"Psychosomatics"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-240","article-title":"Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium","volume":"13","author":"Yoon HJ","year":"2013","unstructured":"Yoon HJ, Park KM, Choi WJ, Choi SH, Park JY, Kim JJ, Seok JH. Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium. BMC Psychiatry. 2013, 13:240. 10.1186\/1471-244X-13-240","journal-title":"BMC Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003071","article-title":"Sedation intensity in the first 48 hours of mechanical ventilation and 180-day mortality: a multinational prospective longitudinal cohort study","volume":"46","author":"Shehabi Y","year":"2018","unstructured":"Shehabi Y, Bellomo R, Kadiman S, et al.. Sedation intensity in the first 48 hours of mechanical ventilation and 180-day mortality: a multinational prospective longitudinal cohort study. Crit Care Med. 2018, 46:850-9. 10.1097\/CCM.0000000000003071","journal-title":"Crit Care Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311049","article-title":"Antipsychotic medications for the treatment of delirium: a systematic review and meta-analysis of randomised controlled trials","volume":"87","author":"Kishi T","year":"2016","unstructured":"Kishi T, Hirota T, Matsunaga S, Iwata N. Antipsychotic medications for the treatment of delirium: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry. 2016, 87:767-74. 10.1136\/jnnp-2015-311049","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903043400901","article-title":"A multicomponent intervention to prevent delirium in hospitalized older patients","volume":"340","author":"Inouye SK","year":"1999","unstructured":"Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999, 340:669-76. 10.1056\/NEJM199903043400901","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.22.2644","article-title":"Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial","volume":"298","author":"Pandharipande PP","year":"2007","unstructured":"Pandharipande PP, Pun BT, Herr DL, et al.. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007, 298:2644-53. 10.1001\/jama.298.22.2644","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/141872-pharmacologic-management-of-intensive-care-unit-delirium-and-the-impact-on-the-duration-of-delirium-length-of-intensive-care-unit-stay-and-30-day-mortality-a-network-meta-analysis-of-randomized-control-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:15Z","timestamp":1707508275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/141872-pharmacologic-management-of-intensive-care-unit-delirium-and-the-impact-on-the-duration-of-delirium-length-of-intensive-care-unit-stay-and-30-day-mortality-a-network-meta-analysis-of-randomized-control-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.35843","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,6]]}}}